RAPT FY 2023 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$127M

Net Income

-$117M

EPS (Diluted)

$-24.37

Cash Flow

Operating Cash Flow

-$97M

Free Cash Flow

-$98M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$173M

Total Liabilities

$26M

Stockholders' Equity

$147M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	$0	$2M	-100.0%
Operating Income	-$127M	-$86M	-48.1%
Net Income	-$117M	-$84M	-39.3%